Dr. Eid Haddad received his Ph.D. from The Pennsylvania State University (PSU), and worked as a Post-Doctoral Fellow at PSU, then as a Post-Doctoral Research Associate at The University of Arkansas, USA. Dr. Haddad is an Assistant Professor of Physiology at Fayetteville State University, a constituent institution of The University of North Carolina. Prior to that, Dr. Haddad worked at ImmunoBio Inc. (IBI) as Senior Research Scientist and later became the Vice President of Research and Development. While at IBI, he was a visiting scientist at the Department of Molecular Biomedical Sciences, North Carolina State University. He conducted research on application of a novel vaccine technology toward the development of viral and bacterial vaccines for mammalian including human applications. Prior to that, he held several research and managerial positions at Embrex Inc. with the last position being Senior Manager of Global Product Development. He worked on the development of veterinary viral vaccines against several economically important veterinary diseases. His research led to the company gaining regulatory approval for two viral vaccines here in the USA, and for one of them in multiple countries. Dr. Haddad and his colleagues published many articles in Vaccinology, Immunology, and Endocrinology in high quality peer-reviewed scientific journals and presented his work at multiple national and international conferences.